K-111
K-111 (BM-170744) is an oral active PPAR alpha agonist. K-111 show efficacy in improving insulin resistance, reducing body weight, and ameliorating atherogenic dyslipidemia. K-111 can be used for study of type 2 diabetes, dyslipidaemia, obesity and the metabolic syndrome.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 221564-97-2
- 分子式: C18H25Cl3O2
- 分子量:379.75
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
化学情報
-
CAS 番号 221564-97-2
-
分子量 379.75
-
分子式 C18H25Cl3O2
-
SMILES
O=C(C(Cl)(CCCCCCCCCCC1=CC=C(C=C1)Cl)Cl)O
-
別名
BM 17.0744
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Schäfer SA, et al. Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)alpha activator, in non-human primates. Biochem Pharmacol. 2004;68(2):239-251. [Content Brief]
[2]. Ortmeyer HK, et al. Skeletal muscle glycogen synthase subcellular localization: effects of insulin and PPAR-alpha agonist (K-111) administration in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol. 2005;288(6):R1509-R1517. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
K-111 関連分類
HY-120943 関連分類
Powered by Bioz
Keywords
- K-111
- 221564-97-2
- BM 17.0744
- K111
- K 111
- PPAR
- K-111 (BM-170744) is an oral active PPAR alpha agonist. K-111 show efficacy in improving insulin resistance
- reducing body weight
- and ameliorating atherogenic dyslipidemia. K-111 can be used for study of type 2 diabetes
- dyslipidaemia
- obesity and the metabolic syndrome[1][2].
- Inhibitor
- inhibitor
- inhibit